Chemokine gene polymorphisms in idiopathic anterior uveitis

Cytokine

Volumn 35, Issue 1-2, 2006, Pages 29-35

  Yeo, Tun K ^a   Ahad, Muhammad A ^a,b   Kuo, Ni wen ^b   Spagnolo, Paolo ^c   Menezo, Victor ^a,b   Lympany, Penny ^c   Lightman, Sue ^a,b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

Author keywords

Chemokines; HLA B27; MCP 1; Polymorphism; Uveitis

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR1; HLA B27 ANTIGEN; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1;

ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE; GENE FREQUENCY; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HUMAN; IDIOPATHIC DISEASE; IRIDOCYCLITIS; MAJOR CLINICAL STUDY; MARKER GENE; NUCLEOTIDE SEQUENCE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM;

CHEMOKINES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, CHEMOKINE; UVEITIS, ANTERIOR;

EID: 33749250344     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2006.07.004     Document Type: Article

References (46)

1. Careless D.J., Chiu B., Rabinovitch T., Wade J., and Inman R.D. Immunogenetic and microbial factors in acute anterior uveitis. J Rheumatol 24 1 (1997) 102-108
2. Magone M.T., and Whitcup S.M. Mechanisms of intraocular inflammation. Chem Immunol 73 (1999) 90-119
3. Zlotnik A., and Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12 2 (2000) 121-127
4. Mo J.S., Matsukawa A., Ohkawara S., and Yoshinaga M. Role and regulation of IL-8 and MCP-1 in LPS-induced uveitis in rabbits. Exp Eye Res 68 3 (1999) 333-340
5. Verma M.J., Mukaida N., Vollmer-Conna U., Matsushima K., Lloyd A., and Wakefield D. Endotoxin-induced uveitis is partially inhibited by anti-IL-8 antibody treatment. Invest Ophthalmol Vis Sci 40 11 (1999) 2465-2470
6. Tuaillon N., de Shen F., Berger R.B., Lu B., Rollins B.J., and Chan C.C. MCP-1 expression in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 43 5 (2002) 1493-1498
7. Manczak M., Jiang S., Orzechowska B., and Adamus G. Crucial role of CCL3/MIP-1alpha in the recurrence of autoimmune anterior uveitis induced with myelin basic protein in Lewis rats. J Autoimmun 18 4 (2002) 259-270
8. Verma M.J., Lloyd A., Rager H., Strieter R., Kunkel S., Taub D., et al. Chemokines in acute anterior uveitis. Curr Eye Res 16 12 (1997) 1202-1208
9. Stabler T., Piette J.C., Chevalier X., Marini-Portugal A., and Kraus V.B. Serum cytokine profiles in relapsing polychondritis suggest monocyte/macrophage activation. Arthritis Rheum 50 11 (2004) 3663-3667
10. Salmeri F.M., Sofo V., Ando F.G., Vastola M.B., Crosca S., Bitto A., Gaeta M., and Girbino G. Imbalance of serum cytokine network in sarcoid patients: index of sarcoidosis relapse?. Sarcoidosis Vasc Diffuse Lung Dis 20 1 (2003) 53-61
11. De Benedetti F., Pignatti P., Bernasconi S., Gerloni V., Matsushima K., Caporali R., et al. Interleukin 8 and monocyte chemoattractant protein-1 in patients with juvenile rheumatoid arthritis. Relation to onset types, disease activity, and synovial fluid leukocytes. J Rheumatol 26 2 (1999) 425-431
12. Wallace G.R., Farmer I., Church A., Graham E.M., and Stanford M.R. Serum levels of chemokines correlate with disease activity in patients with retinal vasculitis. Immunol Lett 90 1 (2003) 59-64
13. Klok A.M., Luyendijk L., Zaal M.J., Rothova A., Hack C.E., and Kijlstra A. Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitis. Br J Ophthalmol 82 8 (1998) 871-874
14. Zouboulis C.C., Katsantonis J., Ketteler R., Treudler R., Kaklamani E., Hornemann S., et al. Adamantiades-Behcet's disease: interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells. Arch Dermatol Res 292 6 (2000) 279-284
15. Wang L.M., Kitteringham N., Mineshita S., Wang J.Z., Nomura Y., Koike Y., et al. The demonstration of serum interleukin-8 and super oxide dismutase in Adamantiades-Behcet's disease. Arch Dermatol Res 289 8 (1997) 444-447
16. Ahuja S.K., and Murphy P.M. The CXC chemokines growth-regulated oncogene (GRO) alpha, GRO, GRO, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor. J Biol Chem 271 (1996) 20545-20550
17. Jones S.A., Wolf M., Qin S., Mackay C.R., and Baggiolini M. Different functions for the interleukin 8 receptors (IL-8R) of human neutrophil leukocytes: NADPH oxidase and phospholipase D are activated through IL-8R1 but not IL-8R2. Proc Natl Acad Sci USA 93 13 (1996) 6682-6686
18. Adamus G., Manczak M., and Machnicki M. Expression of CC chemokines and their receptors in the eye in autoimmune anterior uveitis associated with EAE. Invest Ophthalmol Vis Sci 42 12 (2001) 2894-2903
19. Keino H., Takeuchi M., Kezuka T., Yamakawa N., Tsukahara R., and Usui M. Chemokine and chemokine receptor expression during experimental autoimmune uveoretinitis in mice. Graefes Arch Clin Exp Ophthalmol 241 2 (2003) 111-115
20. Fang I.M., Yang C.H., Lin C.P., Yang C.M., and Chen M.S. Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis. Exp Eye Res 78 6 (2004) 1043-1055
21. Rovin B.H., Lu L., and Zhang X. A novel interleukin-8 polymorphism is associated with severe systemic lupus erythematosus nephritis. Kidney Int 62 1 (2002) 261-265
22. Hull J., Thomson A., and Kwiatkowski D. Association of respiratory syncytial virus bronchiolitis with the interleukin 8 gene region in UK families. Thorax 55 12 (2000) 1023-1027
23. Rovin B.H., Lu L., and Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 259 2 (1999) 344-348
24. Kostrikis L.G., Huang Y., Moore J.P., Wolinski S.M., Zhang L., Guo Y., et al. A chemokine receptor CCR2 allele delays HIV-1 disease progression and is associated with a CCR5 promoter mutation. Nature Med 4 (1998) 350-353
25. Hizawa N., Yamaguchi E., Furuya K., Jinushi E., Ito A., and Kawakami Y. The role of the C-C chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population. Am J Respir Crit Care Med 159 (1999) 2021-2023
26. Petrek M., Drabek J., Kolek V., Zlamal J., Welsh K.I., Bunce M., et al. CC chemokine receptor gene polymorphisms in Czech patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 162 (2000) 1000-1003
27. Miyagishi R., Niino M., Fukazawa T., Yabe I., Kikuchi S., and Tashiro K. C-C chemokine receptor 2 gene polymorphism in Japanese patients with multiple sclerosis. J Neuroimmunol 145 1-2 (2003) 135-138
28. Bunce M., O'Neill C.M., Barnardo M.C., Krausa P., Browning M.J., Morris P.J., et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 and DQB1 by PCR with 144 primers mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 46 (1995) 355-367
29. Adamus G., Machnicki M., Amundson D., Adlard K., and Offner H. Similar pattern of MCP-1 expression in spinal cords and eyes of Lewis rats with experimental autoimmune encephalomyelitis associated anterior uveitis. J Neurosci Res 50 4 (1997) 531-538
30. Liao C.H., Yao T.C., Chung H.T., See L.C., Kuo M.L., and Huang J.L. Polymorphisms in the promoter region of RANTES and the regulatory region of monocyte chemoattractant protein-1 among Chinese children with systemic lupus erythematosus. J Rheumatol 31 10 (2004) 2062-2067
31. Kroner A., Maurer M., Loserth S., Kleinschnitz C., Hemmer B., Rosche B., et al. Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in patients with multiple sclerosis. Tissue Antigens 64 1 (2004) 70-73
32. Steinmetz O.M., Panzer U., Harendza S., Mertens P.R., Ostendorf T., Floege J., et al. No association of the -2518 MCP-1 A/G promoter polymorphism with incidence and clinical course of IgA nephropathy. Nephrol Dial Transplant 19 3 (2004) 596-601
33. Gonzalez-Escribano M.F., Torres B., Aguilar F., Rodriguez R., Garcia A., Valenzuela A., et al. MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis. Hum Immunol 64 7 (2003) 741-744
34. Hwang S.Y., Cho M.L., Park B., Kim J.Y., Kim Y.H., Min D.J., et al. Allelic frequency of the MCP-1 promoter -2518 polymorphism in the Korean population and in Korean patients with rheumatoid arthritis, systemic lupus erythematosus and adult-onset Still's disease. Eur J Immunogenet 29 5 (2002) 413-416
35. Karrer S., Bosserhoff A.K., Weiderer P., Distler O., Landthaler M., Szeimies R.M., et al. The -2518 promotor polymorphism in the MCP-1 gene is associated with systemic sclerosis. J Invest Dermatol 124 1 (2005) 92-98
36. Letendre S., Marquie-Beck J., Singh K.K., De Almeida S., Zimmerman J., Spector S.A., et al. Hnrc group. The monocyte chemotactic protein-1 -2578g allele is associated with elevated mcp-1 concentrations in cerebrospinal fluid. J Neuroimmunol 157 1-2 (2004) 193-196
37. Tabara Y., Kohara K., Yamamoto Y., Igase M., Nakura J., Kondo I., et al. Polymorphism of the monocyte chemoattractant protein (MCP-1) gene is associated with the plasma level of MCP-1 but not with carotid intima-media thickness. Hypertens Res 26 9 (2003) 677-683
38. Gonzalez E., Rovin B.H., Sen L., Cooke G., Dhanda R., Mummidi S., et al. HIV-1 infection and AIDS dementia are influenced by a mutant MCP-1 allele linked to increased monocyte infiltration of tissues and MCP-1 levels. Proc Natl Acad Sci USA 99 21 (2002) 13795-13800
39. Modi W.S., Goedert J.J., Strathdee S., Buchbinder S., Detels R., Donfield S., et al. MCP-1-MCP-3-Eotaxin gene cluster influences HIV-1 transmission. AIDS 17 16 (2003) 2357-2365
40. TESS: Transcription Element Search Software on the WWW, Jonathan Schug and G. Christian Overton, Technical Report CBIL-TR-1997-1001-v0.0 Computational Biology and Informatics Laboratory, School of Medicine, University of Pennsylvania, 1997.
41. Venturelli D., Travali S., and Calabretta B. Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression. Proc Natl Acad Sci USA 87 15 (1990) 5963-5967
42. Marinescu V.D., Kohane I.S., and Riva A. MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics 6 1 (2005) 79
43. Yang C.H., Fang I.M., Lin C.P., Yang C.M., and Chen M.S. Effects of the NF-κB inhibitor pyrrolidine dithiocarbamate on experimentally induced autoimmune anterior uveitis. Invest Ophthalmol Vis Sci 46 4 (2005) 1339-1347
44. Cahill C.M., Waterman W.R., Xie Y., Auron P.E., and Calderwood S.K. Transcriptional repression of the prointerleukin 1 gene by heat shock factor 1. J Biol Chem 271 (1996) 24874-24879
45. Singh I.S., He J.R., Calderwood S., and Hasday J.D. A high affinity HSF-1 binding site in the 5′-untranslated region of the murine tumor necrosis factor-gene is a transcriptional repressor. J Biol Chem 277 (2002) 4981-4988
46. Wegscheider B.J., Weger M., Renner W., Posch U., Ulrich S., Hermann J., et al. Role of the CCL2/MCP-1 -2518A > G gene polymorphism in HLA-B27 associated uveitis. Mol Vis 11 (2005) 896-900